Drug intelligence / Profile preview

8-pCPT-2'-O-Me-cAMP-AM

Development stage
Unknown
Modality
Small Molecules
01

Overview

8-pCPT-2'-O-Me-cAMP-AM (also known as 007-AM) is a cell-permeable, selective small molecule activator of the exchange protein directly activated by cyclic AMP (Epac). It is the acetoxymethyl (AM) ester prodrug of 8-pCPT-2'-O-Me-cAMP. Once inside cells, intracellular esterases cleave the AM ester to release the active Epac agonist. 8-pCPT-2'-O-Me-cAMP-AM is highly selective for Epac (primarily Epac1) over protein kinase A (PKA). It is widely utilized as a research reagent to study Epac-mediated signaling pathways, including endothelial junction tightening, insulin secretion in pancreatic beta-cells, and renal protection against ischemia-reperfusion injury. It is not clinically developed or approved for therapeutic use in humans.

Other names
007-AM8-(4-chlorophenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate acetoxymethyl ester8-pCPT-2'-O-Me-cAMP acetoxymethyl ester
02

Targets

EPAC1 (Rap guanine nucleotide exchange factor 3)

Beyond the preview

Go deeper on 8-pCPT-2'-O-Me-cAMP-AM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8-pCPT-2'-O-Me-cAMP-AM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call